BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16638703)

  • 1. Liver TX for hepatitis C cirrhosis in a low prevalence population: risk factors and status at evaluation.
    Melum E; Schrumpf E; Bjøro K
    Scand J Gastroenterol; 2006 May; 41(5):592-6. PubMed ID: 16638703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C impairs survival following liver transplantation irrespective of concomitant hepatocellular carcinoma.
    Melum E; Friman S; Bjøro K; Rasmussen A; Isoniemi H; Gjertsen H; Bäckman L; Oksanen A; Olausson M; Duraj FF; Ericzon BG
    J Hepatol; 2007 Dec; 47(6):777-83. PubMed ID: 17714825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus-related cirrhosis as a significant mortality factor in intention-to-treat analysis in liver transplantation.
    Gringeri E; Vitale A; Brolese A; Zanus G; Boccagni P; Neri D; Valmasoni M; D'Amico F; Ciarleglio FA; Carraro A; Pauletto A; Violi P; Bassi D; D'Amico F; D'Amico DF; Cillo U
    Transplant Proc; 2007; 39(6):1901-3. PubMed ID: 17692648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation for HCV cirrhosis at Karolinska University Hospital Huddinge, Stockholm.
    Gjertsen H; Weiland O; Oksanen A; Söderdahl G; Broomé U; Ericzon BG
    Transplant Proc; 2006 Oct; 38(8):2675-6. PubMed ID: 17098036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection.
    Neff GW; O'Brien CB; Nery J; Shire NJ; Nishida S; delaGarza J; Montalbano M; Safdar K; Ruiz P; Rideman E; Gascon JA; Tzakis AG; Madariaga J; Rudich SM
    Liver Transpl; 2004 Dec; 10(12):1497-503. PubMed ID: 15558835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of liver transplantation for patients infected by hepatitis C, including those infected by genotype 4.
    Wali MH; Heydtmann M; Harrison RF; Gunson BK; Mutimer DJ
    Liver Transpl; 2003 Aug; 9(8):796-804. PubMed ID: 12884191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation.
    Botha JF; Thompson E; Gilroy R; Grant WJ; Mukherjee S; Lyden ER; Fox IJ; Sudan DL; Shaw BW; Langnas AN
    Liver Int; 2007 Aug; 27(6):758-63. PubMed ID: 17617118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural history of hepatitis C cirrhosis after liver transplantation.
    Firpi RJ; Clark V; Soldevila-Pico C; Morelli G; Cabrera R; Levy C; Machicao VI; Chaoru C; Nelson DR
    Liver Transpl; 2009 Sep; 15(9):1063-71. PubMed ID: 19718647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
    Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
    Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
    Yosry A; Esmat G; El-Serafy M; Omar A; Doss W; Said M; Abdel-Bary A; Hosny A; Marawan I; El-Malt O; Kamel RR; Hatata Y; Ghali A; Sabri H; Kamel S; El-Gbaly H; Tanaka K
    Transplant Proc; 2008 Jun; 40(5):1481-4. PubMed ID: 18589133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O; Perrella A; Arenga G
    Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C infection and survivals of liver transplant patients in Canada, 1997-2003.
    Hong Z; Smart G; Dawood M; Kaita K; Wen SW; Gomes J; Wu J
    Transplant Proc; 2008 Jun; 40(5):1466-70. PubMed ID: 18589130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of liver transplantation in the Department of General, Transplant and Liver Surgery at the Medical University of Warsaw in patients with chronic hepatitis B and C viruses infection.
    Krawczyk M; Grat M; Kornasiewicz O; Lewandowski Z; Barski K; Ligocka J; Grat K; Antczak A; Skalski M; Patkowski W; Nyckowski P; Zieniewicz K; Grzelak I; Pawlak J; Alsharabi A; Wróblewski T; Paluszkiewicz R; Najnigier B; Dudek K; Remiszewski P; Smoter P; Grodzicki M; Korba M; Kotulski M; Cieślak B; Kalinowski P; Gierej P; Fraczek M; Rdzanek Ł; Stankiewicz R; Kobryń K; Nazarewski Ł; Giercuszkiewicz D; Piwowarska J; Brudkowska A; Andrzejewska R; Niewiński G; Kilińska B; Zarzycka A; Nowak R; Kosiński C; Korta T; Ołdakowska-Jedynak U; Sańko-Resmer J; Foroncewicz B; Ziółkowski J; Mucha K; Senatorski G; Paczek L; Habior A; Lechowicz R; Polański S; Pacho R; Andrzejewska M; Rowiński O; Kozieł S; Ziarkiewicz-Wróblewska B; Górnicka B; Hevelke P; Cianciara J; Wiercińska-Drapało A; Michałowicz B; Karwowski A; Szczerbań J
    Przegl Epidemiol; 2013; 67(1):5-10, 93-7. PubMed ID: 23745368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular adsorbents recirculating system treatment in acute-on-chronic hepatitis patients on the transplant waiting list improves model for end-stage liver disease scores.
    Novelli G; Rossi M; Pugliese F; Poli I; Ruberto E; Martelli S; Nudo F; Morabito V; Mennini G; Berloco PB
    Transplant Proc; 2007; 39(6):1864-7. PubMed ID: 17692635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent hepatitis C virus disease after liver transplantation and concurrent biliary tract complications: poor outcome.
    Katz LH; Mor E; Brown M; Bar-Nathan N; Shaharabani E; Sulkes J; Pappo O; Tur-Kaspa R; Ben-Ari Z
    Clin Transplant; 2006; 20(4):465-70. PubMed ID: 16842523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
    Belli LS; Burroughs AK; Burra P; Alberti AB; Samonakis D; Cammà C; De Carlis L; Minola E; Quaglia A; Zavaglia C; Vangeli M; Patch D; Dhillon A; Cillo U; Guido M; Fagiuoli S; Giacomoni A; Slim OA; Airoldi A; Boninsegna S; Davidson BR; Rolles K; Pinzello G
    Liver Transpl; 2007 May; 13(5):733-40. PubMed ID: 17370330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C.
    Burra P
    Semin Liver Dis; 2009 Feb; 29(1):53-65. PubMed ID: 19235659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retransplantation for hepatitis C: results of a U.S. multicenter retransplant study.
    McCashland T; Watt K; Lyden E; Adams L; Charlton M; Smith AD; McGuire BM; Biggins SW; Neff G; Burton JR; Vargas H; Donovan J; Trotter J; Faust T
    Liver Transpl; 2007 Sep; 13(9):1246-53. PubMed ID: 17763405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
    Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.